Our research aims to clarify the core role of SIRT6 in metabolic regulation in colorectal cancer, uncover its anti-cancer mechanisms, identifying TFAM as a promising therapeutic target and provide theoretical support for developing targeted therapeutic strategies based on SIRT6. This evidence concerns the gene SIRT6 and colorectal cancer.